# DOCOSANOL
> **ANDA212385** · Abbreviated New Drug Application (Generic) · Sponsor: P AND L DEVELOPMENT · Approved 2022-10-07
## Drug
- **FDA Application Number:** ANDA212385
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DOCOSANOL
- **Generic name:** DOCOSANOL
- **Active ingredients:** DOCOSANOL
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Over-the-counter
- **Sponsor:** P AND L DEVELOPMENT
- **Manufacturer:** H2-Pharma, LLC
- **First approval:** 2022-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212385)
---
*AI Analytics · CC0 1.0*